$SMR

NuScale Power (NYSE: SMR), the only SMR provider with NRC design approval, faces challenges despite its competitive advantage. It lacks binding commercial agreements, reported Q2 revenue of $75k (vs. $9M estimate), and a widened net loss of $50.1M. The company has $2B in cash and no debt but is involved in a lawsuit alleging misleading investors. Its stock trades below $6.

Cathie Wood's Ark Invest ETFs purchased shares of X-Energy (XE) and Oklo, investing approximately $5.1 million and $4.1 million respectively. X-Energy's shares were added to ARKK, ARKQ, and ARKX, while Oklo was added to ARKQ. Both companies are involved in nuclear energy, with X-Energy focusing on SMR design and nuclear fuel production, and Oklo developing nuclear fuel recycling and isotope production.

Analysts made notable moves this week: Bernstein upgraded Datadog (DDOG) to Outperform with a $350 target, JPMorgan upgraded Intel (INTC) to Neutral, Barclays downgraded NuScale Power (SMR) to Underweight, Piper Sandler upgraded DigitalOcean (DOCN) to Overweight, and RBC downgraded Mobileye (MBLY) to Underperform. Nokia (NOK) also received upgrades from multiple firms. The article highlights a trend of upgrades for stocks that had sold off and downgrades for weaker or rate-sensitive stocks.

Oklo (OKLO) shares dropped 4% after Truist reduced its price target to $31 from $51, maintaining a Hold rating. This follows similar cuts from Piper Sandler, Barclays, and Citi this week. Analysts expect minimal revenue until 2028, with Oklo's stock performance tied to future reactor success. NuScale Power (SMR) also fell 2% amid broader market declines and bearish analyst sentiment.

CRWV, SMR, and FRMI stocks fell to 52-week lows on Tuesday due to debt concerns, commercial delays, and broader AI sector pressures. CRWV closed up 1.6%, SMR down 2%, and FRMI down 2.65%. HSBC reiterated a 'Reduce' rating on CRWV with a $39 target. Barclays downgraded SMR to 'Underweight' with a $5 target. Cantor Fitzgerald cut FRMI's target to $8 but maintained an 'Overweight' rating.

Bloom Energy (BE) and nuclear power companies Oklo (OKLO), NuScale (SMR), X-Energy (XE), and Nano Nuclear (NNE) saw stock rises overnight after Elon Musk highlighted power infrastructure as a key constraint for AI growth. BE surged 6% in extended trading, while others gained 1-2%. Musk's SpaceX reported strong Q3 earnings, with AI-related revenue at $7.56 billion. Analysts and investors linked Musk's comments to increased demand for energy solutions.

U.S. stock index futures were mixed on Tuesday, with tech stocks under pressure. Halliburton (HAL) rose 3.4% after beating earnings expectations. Rapport Therapeutics (RPTX) surged 31.1% on positive Phase 2 trial results. NuScale Power (SMR) fell 6.5% after a downgrade. Akamai (AKAM) gained 2.2% following an upgrade. General Motors (GM) dropped 6.3% after disappointing investors with its outlook. Alvotech (ALVO) rose 7% after FDA approval. 3M (MMM) gained over 1% on Amazon partnership expansion.

Nuscale Power's stock dropped 6.5% in pre-market trading after Barclays downgraded it to Underweight and cut its price target to $5 from $11. The company faces multiple analyst downgrades, legal investigations, and dilution concerns. Its stock is near a 52-week low of $5.44, with weak customer commitments and expected negative free cash flow contributing to the decline.

NuScale Power (SMR) trades below $6, down 90% from its peak. The company develops small modular reactors (SMRs) for data centers and industrial plants. A potential deal with the Tennessee Valley Authority (TVA) for up to 6 GW of power could boost its outlook, but the stock remains risky without firm commitments.

NuScale Power (SMR) stock has fallen 86.6% this year, despite a 17.9% rise in the S&P 500. The company's market value is $2.64B, with $1.89B in cash and no debt. Revenue was $75K in Q2, with an operating loss of $64M. Management expects revenue in 2027 if a Romanian reactor contract is finalized, pending regulatory approval.